Hutch News

Hutch News

Stories tagged 'h pylori'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 14, 2017

Fred Hutchinson Cancer Research Center has announced awards totaling $1 million to nine of its scientists through the Evergreen Fund, a unique grant program that supports homegrown research projects deemed attractive to potential commercial partners. This is the second year of Evergreen Fund awards. This is the second year of Evergreen Fund awards. The Hutch’s Business Development & Strategy office created the program in 2016 in an effort to encourage scientists to pursue creative ideas with commercial appeal. The goal is to speed research from the bench to the bedside while generating income from patent rights and partnerships with the business sector.

View story >


'You create your path': Panel of 'Rock Star Women in Science' inspire crowd

Top scientists from five research organizations spoke to sold out crowd about passion, science, confidence and pear farming

June 23, 2016 | By Rachel Tompa / Fred Hutch News Service

Female scientists from five Seattle research organizations spoke Wednesday night at "Rock Star Women in Science" at Seattle's Town Hall. Fred Hutch organized the public event, which drew an audience of nearly 800.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 10, 2016

Drs. Michael Emerman and Nina Salama elected to Fellowship in the American Academy of Microbiology; Dr. William Grady receives grant for esophageal cancer screening study; Dr. Andrew Hsieh earns 2016 ASCI Young Physician-Scientist Award; New interactive map is hub for global breast cancer data

View story >


Bug out: Killing common bacteria may curb stomach cancer, studies show

Will H. pylori be targeted for full eradication?

July 21, 2015 | By Bill Briggs / Fred Hutch News Service

Permanently wiping out H. pylori with a brief blitz of antibiotics plus an acid-suppressing medication may cut the risk of stomach cancers, asserts a paper published Tuesday.

View story >


Three-drug H. pylori therapy better for some than four

New results from large Latin American SWOG study contradict clinical trial findings in Europe and Asia; geographic variations in antibiotic resistance may validate different drug regimens for different populations

Aug. 1, 2011

A large clinical trial at seven sites across Latin America has found that a standard three-drug regimen for treating H. pylori is more effective in the population studied than either of two four-drug regimens that proved superior in studies in Europe and Asia.

View story >


Salama, colleagues unlock ulcer bug’s structure

H. pylori’s corkscrew twist allows colonization; findings may lead to better drugs

June 1, 2010 | By Kristen Woodward

For the first time, Fred Hutchinson Cancer Research Center researchers have found that, at least when it comes to H. pylori’s ability to colonize the stomach, shape indeed matters. Dr. Nina Salama, a microbiologist in the Human Biology Division, and colleagues reported their findings May 28 in Cell.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.